Cardiovascular Systems Inc 4
4 · Cardiovascular Systems Inc · Filed Jun 2, 2017
Insider Transaction Report
Form 4
Koehn Paul A
VP of Manufacturing
Transactions
- Exercise/Conversion
Common Stock
2017-05-31$7.90/sh+12,940$102,226→ 96,929 total - Exercise/Conversion
Stock Option (right to buy)
2017-05-31−12,940→ 0 totalExercise: $7.90Exp: 2017-10-08→ Common Stock (12,940 underlying) - Exercise/Conversion
Common Stock
2017-05-31$12.15/sh+7,060$85,779→ 103,989 total - Sale
Common Stock
2017-05-31$29.98/sh−20,000$599,660→ 83,989 total - Exercise/Conversion
Stock Option (right to buy)
2017-05-31−7,060→ 17,060 totalExercise: $12.15Exp: 2017-12-11→ Common Stock (7,060 underlying)
Holdings
- 8,087
Stock Option (right to buy)
Exercise: $8.75Exp: 2019-03-01→ Common Stock (8,087 underlying)
Footnotes (3)
- [F1]Includes 602 shares acquired under Cardiovascular Systems, Inc.'s stock purchase plan on December 31, 2016.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.96 to $30.01 inclusive. The reporting person undertakes to provide Cardiovascular Systems, Inc., any security holder of Cardiovascular Systems, Inc., or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F3]Fully exercisable.